We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
-7.74%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.6B
AUM Growth
-$392M
Cap. Flow
-$203M
Cap. Flow %
-12.69%
Top 10 Hldgs %
25.61%
Holding
503
New
74
Increased
178
Reduced
101
Closed
74

Top Buys

1
DGX icon
Quest Diagnostics
DGX
+$24.5M
2
CHD icon
Church & Dwight Co
CHD
+$19.6M
3
ES icon
Eversource Energy
ES
+$18.2M
4
EXPE icon
Expedia Group
EXPE
+$17.6M
5
KMB icon
Kimberly-Clark
KMB
+$17.5M

Top Sells

1
GILD icon
Gilead Sciences
GILD
+$31.2M
2
CAG icon
Conagra Brands
CAG
+$27M
3
SEE
Sealed Air
SEE
+$22.8M
4
LLY icon
Eli Lilly
LLY
+$22.1M
5
REG icon
Regency Centers
REG
+$20.3M

Sector Composition

1 Healthcare 28%
2 Consumer Staples 25.89%
3 Communication Services 10.3%
4 Technology 7.09%
5 Materials 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GFL icon
176
GFL Environmental
GFL
$14.3B
$446K 0.03%
17,356
-184,596
-91% -$5.47M
OMC icon
177
Omnicom Group
OMC
$24B
$435K 0.03%
6,844
+5,910
+633% +$437K
ROST icon
178
Ross Stores
ROST
$74.7B
$425K 0.03%
6,048
+4,237
+234% +$377K
RGEN icon
179
Repligen
RGEN
$8.38B
$404K 0.03%
2,488
+2,228
+857% +$352K
EBAY icon
180
eBay
EBAY
$49.2B
$402K 0.03%
9,652
-92,612
-91% -$4.51M
MRSH
181
Marsh
MRSH
$87.8B
$401K 0.03%
2,585
+212
+9% +$34K
DXCM icon
182
DexCom
DXCM
$30.1B
$400K 0.03%
5,368
+696
+15% +$63.5K
ADI icon
183
Analog Devices
ADI
$185B
$393K 0.02%
+2,688
New +$423K
WM icon
184
Waste Management
WM
$97.3B
$389K 0.02%
2,543
+608
+31% +$95.2K
RF icon
185
Regions Financial
RF
$27.6B
$388K 0.02%
20,707
+17,165
+485% +$354K
MMM icon
186
3M
MMM
$84.4B
$387K 0.02%
3,575
+287
+9% +$34.7K
AXP icon
187
American Express
AXP
$247B
$386K 0.02%
2,785
+1,152
+71% +$190K
WAT icon
188
Waters Corp
WAT
$37.1B
$380K 0.02%
1,148
+877
+324% +$278K
BKNG icon
189
Booking.com
BKNG
$143B
$360K 0.02%
5,150
+875
+20% +$74.7K
NLY icon
190
Annaly Capital Management
NLY
$17.2B
$354K 0.02%
14,966
+4,925
+49% +$128K
CSCO icon
191
Cisco
CSCO
$432B
$348K 0.02%
8,151
+688
+9% +$32.9K
PNC icon
192
PNC Financial Services
PNC
$102B
$348K 0.02%
2,205
+199
+10% +$33.4K
ROP icon
193
Roper Technologies
ROP
$36.8B
$346K 0.02%
877
+523
+148% +$227K
SYK icon
194
Stryker
SYK
$127B
$340K 0.02%
+1,709
New +$401K
MS icon
195
Morgan Stanley
MS
$343B
$336K 0.02%
+4,415
New +$362K
KDP icon
196
Keurig Dr Pepper
KDP
$42.7B
$327K 0.02%
9,228
-2,961
-24% -$107K
TFC icon
197
Truist Financial
TFC
$66.3B
$326K 0.02%
6,867
+3,735
+119% +$184K
TJX icon
198
TJX Companies
TJX
$171B
$316K 0.02%
5,652
+573
+11% +$34.7K
CNC icon
199
Centene
CNC
$31.5B
$308K 0.02%
3,637
+1,534
+73% +$127K
GE icon
200
GE Aerospace
GE
$361B
$307K 0.02%
7,738
+1,403
+22% +$68K
6 7
8
9 10

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q2 2022 Portfolio in Review

As of Q2 2022, TOBAM held 503 positions worth $1.6B, down 20% from $1.99B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

TOBAM withdrew a net $203M in Q2 2022, closing 74 positions and reducing 101 holdings. Its most notable exit was Novavax, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Staples and Communication Services.

Against the trend, TOBAM opened a new position in Expedia Group worth $11.8M.

  • TOBAM's largest Q2 2022 buy was Expedia Group: 124,451 shares worth $11.8M.
  • TOBAM added most to Quest Diagnostics in Q2 2022, an estimated $24.5M increase.
  • TOBAM's biggest Q2 2022 reduction was Gilead Sciences, cutting an estimated $31.2M.
  • TOBAM fully exited Novavax in Q2 2022, selling an estimated $12.8M.
  • TOBAM's ten largest holdings make up 26% of its $1.6B portfolio in Q2 2022.
  • TOBAM opened 74 new positions and closed 74 in Q2 2022.
  • TOBAM's portfolio value fell 20% quarter-over-quarter to $1.6B.

Based on TOBAM's 13F filing for Q2 2022, filed 2 Aug 2022.